Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
PALGA, the nationwide network and registry of histo- and cytopathology in the Netherlands, Houton, the Netherlands.
Acta Obstet Gynecol Scand. 2019 Jun;98(6):737-746. doi: 10.1111/aogs.13547. Epub 2019 Feb 27.
The aim of this study was to describe trends in the diagnosis and treatment of women referred from the national screening program with cervical intraepithelial neoplasia (CIN) in the Netherlands, and to compare these trends with national guidelines and identify potential areas for improvement for the new primary high-risk HPV screening program.
We conducted a population-based cohort study using data from the Dutch pathology archive. Women aged 29-63 years who took part in the Dutch cervical screening program between 1 January 2005 and 31 December 2014 were selected. Three referral groups were identified: direct referrals and those referred after either one (first indirect referrals) or two (second indirect referrals) repeat cytology tests, totaling 85 239 referrals for colposcopy. The most invasive management technique and the most severe diagnosis of each screening episode was identified. Rates of management techniques were calculated separately by referral type, highest CIN diagnosis and age group.
In all, 85.1% of CIN 3 lesions were treated with excision (either large excision or hysterectomy) and 26.4% of CIN 1 lesions were treated with large excision. Rates of overtreatment (CIN 1 or less) in see-and-treat management were higher for indirect referrals than for direct referrals and increased with age. Large excision rates increased with CIN diagnosis severity.
Despite guideline recommendations not to treat, CIN 1 lesions were treated in just over 25% of cases and approximately 15% of CIN 3 lesions were possibly undertreated. Given the expected increase in CIN detection in the new primary high-risk HPV screening program, reduction in CIN 1 treatment and CIN 2 treatment in younger women is needed to avoid an increase in potential harm.
本研究旨在描述荷兰全国性宫颈癌筛查项目中,转诊至宫颈癌前病变(CIN)的女性的诊断和治疗趋势,并与国家指南进行比较,为新的高危型 HPV 初筛项目寻找潜在的改进方向。
我们使用荷兰病理学档案中的数据进行了一项基于人群的队列研究。选择了 2005 年 1 月 1 日至 2014 年 12 月 31 日期间参加荷兰宫颈癌筛查项目的 29-63 岁女性。确定了三个转诊组:直接转诊和一次(第一间接转诊)或两次(第二间接转诊)细胞学重复检查后的转诊,共有 85239 例转诊行阴道镜检查。确定了每个筛查阶段最具侵袭性的管理技术和最严重的诊断。根据转诊类型、最高 CIN 诊断和年龄组分别计算管理技术的比率。
所有 CIN3 病变的 85.1%采用切除(大切除或子宫切除术)治疗,CIN1 病变的 26.4%采用大切除治疗。在直接转诊和间接转诊中,观察与治疗管理的过度治疗(CIN1 或更低)率更高,且随年龄增加而升高。大切除率随 CIN 诊断严重程度的增加而增加。
尽管指南建议不治疗,但仍有超过 25%的 CIN1 病变得到治疗,约 15%的 CIN3 病变可能治疗不足。考虑到新的高危型 HPV 初筛项目中 CIN 检出率的预期增加,需要减少年轻女性的 CIN1 治疗和 CIN2 治疗,以避免潜在危害的增加。